If you are a forensic lab dealing with the exponential growth of illicit drug classes — this project developed an AI-assisted spectra management toolkit that allows for faster detection and identification of substances. This reduces the time spent on manual screening and overcomes the lack of commercial reference materials.
AI-Powered Rapid Detection Platform for New Synthetic Drugs and Forensic Analysis
Imagine trying to find a specific needle in a haystack, but the needle keeps changing its shape and color every day. This project builds a smart digital library and a set of high-tech scanners that can spot these changing substances instantly. It's like giving forensic teams a universal search engine that recognizes new illegal drugs even if they've never seen that exact version before.
What needed solving
Forensic labs cannot keep up with the exponential growth of new synthetic drugs because instrument libraries are outdated and reference materials are unavailable. This leads to delays in identifying fatal drug-related substances.
What was built
An AI-assisted spectra management toolkit and a shareable meta-spectra database that integrates data from Raman, IR, HSI, and HRMS instruments.
Who needs this
Who can put this to work
If you are a hardware manufacturer dealing with outdated instrument libraries — this project developed a shareable meta-spectra database. This allows your Raman, IR, and Mass Spectrometry devices to be integrated into an up-to-date diagnostic platform.
If you are a software firm dealing with the slow response time to New Psychoactive Substances — this project developed a multidisciplinary platform that supports the EU Early Warning System. This enables the rapid assessment and response to new drug threats using AI.
Quick answers
What is the cost or price of the platform?
Based on available project data, no pricing or cost information is provided.
Can this be scaled to an industrial level?
The project involves 19 partners across 9 countries, including 3 industry partners, suggesting a design intended for cross-organizational use and scale.
How is the IP or licensing handled?
Based on available project data, specific licensing terms are not mentioned, though it aims to create a shareable reference spectra database.
What is the implementation timeline?
The project period is from 2024-11-01 to 2027-10-31.
How does this integrate with existing hardware?
The platform is designed to adapt orthogonal instruments such as Raman/SERS, IR, HSI, and HRMS for both on-site and laboratory use.
Who built it
The consortium is highly diverse with 19 partners from 9 countries, showing a strong European reach. While dominated by research and university entities (10 total), there is a 16% industry ratio with 3 industrial partners and 2 SMEs, indicating a clear path for translating laboratory findings into commercial tools.
Contact AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENERGIA E LO SVILUPPO ECONOMICO SOSTENIBILE in Italy
Talk to the team behind this work.
Contact us to explore integration opportunities with the NARCOSIS AI toolkit.